AQR Capital Management - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 198 filers reported holding MYRIAD GENETICS INC in Q4 2021. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.

Quarter-by-quarter ownership
AQR Capital Management ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$945,157
-25.6%
58,925
+7.5%
0.00%
-33.3%
Q2 2023$1,270,612
+40.6%
54,815
+40.9%
0.00%
+50.0%
Q1 2023$903,693
-4.4%
38,902
-40.3%
0.00%0.0%
Q4 2022$945,501
-29.0%
65,162
-6.6%
0.00%
-33.3%
Q3 2022$1,331,000
+60.0%
69,755
+52.3%
0.00%
+50.0%
Q2 2022$832,000
-58.1%
45,808
-41.9%
0.00%
-50.0%
Q1 2022$1,987,000
-23.5%
78,849
-16.2%
0.00%
-20.0%
Q4 2021$2,597,000
+54.6%
94,077
+80.8%
0.01%
+66.7%
Q3 2021$1,680,000
+32.9%
52,036
+25.9%
0.00%
+50.0%
Q2 2021$1,264,000
+117.6%
41,323
+116.6%
0.00%
+100.0%
Q1 2021$581,000
-10.2%
19,081
-41.7%
0.00%0.0%
Q4 2020$647,000
-48.8%
32,710
-66.3%
0.00%
-50.0%
Q3 2020$1,264,000
-32.1%
96,941
-40.9%
0.00%
-33.3%
Q2 2020$1,862,000
-6.8%
164,166
+17.6%
0.00%0.0%
Q1 2020$1,998,000
-67.5%
139,646
-38.1%
0.00%
-57.1%
Q4 2019$6,148,000
-28.3%
225,779
-24.6%
0.01%
-30.0%
Q3 2019$8,578,000
+39.6%
299,618
+35.4%
0.01%
+42.9%
Q2 2019$6,146,000
-30.6%
221,255
-17.0%
0.01%
-22.2%
Q1 2019$8,851,000
-5.9%
266,610
-17.6%
0.01%
-18.2%
Q4 2018$9,410,000
-42.7%
323,718
-9.4%
0.01%
-31.2%
Q3 2018$16,433,000
+29.5%
357,251
+5.2%
0.02%
+23.1%
Q2 2018$12,685,000
+16.2%
339,458
-8.1%
0.01%
+8.3%
Q1 2018$10,914,000
-16.0%
369,331
-2.4%
0.01%
-14.3%
Q4 2017$12,996,000
+41.3%
378,377
+48.8%
0.01%
+27.3%
Q3 2017$9,200,000
+67.2%
254,290
+19.4%
0.01%
+57.1%
Q2 2017$5,504,000
-13.5%
213,007
-35.8%
0.01%
-12.5%
Q1 2017$6,366,000
+5.9%
331,563
-8.1%
0.01%0.0%
Q4 2016$6,012,000
-9.3%
360,626
+12.0%
0.01%
-20.0%
Q3 2016$6,629,000
+88.1%
322,100
+179.7%
0.01%
+66.7%
Q2 2016$3,524,000
+30.5%
115,147
+59.6%
0.01%
+20.0%
Q1 2016$2,700,000
+43.7%
72,132
+65.6%
0.01%
+66.7%
Q4 2015$1,879,000
-84.1%
43,551
-86.2%
0.00%
-87.5%
Q3 2015$11,849,000
-58.4%
316,153
-62.3%
0.02%
-57.9%
Q2 2015$28,514,000
-30.7%
838,885
-27.9%
0.06%
-39.4%
Q1 2015$41,173,000
-19.9%
1,163,084
-22.9%
0.09%
-13.0%
Q4 2014$51,383,000
+3.8%
1,508,610
+17.5%
0.11%
-20.6%
Q3 2014$49,508,000
-10.1%
1,283,600
-9.3%
0.14%
-8.1%
Q2 2014$55,061,000
+16.2%
1,414,720
+2.1%
0.15%
+3.5%
Q1 2014$47,379,000
+148.3%
1,385,766
+52.4%
0.14%
+150.9%
Q4 2013$19,079,000
+188.5%
909,383
+223.1%
0.06%
+147.8%
Q3 2013$6,613,000
-11.1%
281,416
+1.6%
0.02%
-11.5%
Q2 2013$7,439,000
-10.5%
276,849
-9.3%
0.03%
-27.8%
Q4 2012$8,315,000305,1220.04%
Other shareholders
MYRIAD GENETICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Camber Capital Management LP 6,635,000$106,4253.51%
Glenview Capital Management 3,783,982$60,695,0711.37%
AMH Equity Ltd 47,285$758,4510.83%
DISCIPLINED GROWTH INVESTORS INC /MN 1,973,312$31,651,9240.75%
EARNEST PARTNERS LLC 3,473,281$55,711,4270.32%
AIMZ Investment Advisors, LLC 40,985$657,3990.29%
PEREGRINE CAPITAL MANAGEMENT LLC 280,767$4,503,5030.13%
Beverly Hills Private Wealth, LLC 19,687$315,7790.09%
Artisan Partners Limited Partnership 2,537,147$40,695,8380.07%
Jump Financial, LLC 84,924$1,362,1810.05%
View complete list of MYRIAD GENETICS INC shareholders